SE398503B - Analogiforfarande for framstellning av derivat av 5,6-dihydro-pyrrolo(3,4-b)pyrazin - Google Patents
Analogiforfarande for framstellning av derivat av 5,6-dihydro-pyrrolo(3,4-b)pyrazinInfo
- Publication number
- SE398503B SE398503B SE7300159A SE7300159A SE398503B SE 398503 B SE398503 B SE 398503B SE 7300159 A SE7300159 A SE 7300159A SE 7300159 A SE7300159 A SE 7300159A SE 398503 B SE398503 B SE 398503B
- Authority
- SE
- Sweden
- Prior art keywords
- pyrazin
- pyrrolo
- dihydro
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7200505A FR2166314A1 (en) | 1972-01-07 | 1972-01-07 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
FR7239731A FR2205318A2 (en) | 1972-11-09 | 1972-11-09 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
Publications (1)
Publication Number | Publication Date |
---|---|
SE398503B true SE398503B (sv) | 1977-12-27 |
Family
ID=26216824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7300159A SE398503B (sv) | 1972-01-07 | 1973-01-05 | Analogiforfarande for framstellning av derivat av 5,6-dihydro-pyrrolo(3,4-b)pyrazin |
Country Status (22)
Country | Link |
---|---|
US (1) | US3862149A (pt) |
JP (3) | JPS523952B2 (pt) |
AR (1) | AR195097A1 (pt) |
AT (1) | AT323181B (pt) |
AU (1) | AU466586B2 (pt) |
BE (1) | BE793730A (pt) |
CA (1) | CA991183A (pt) |
CY (1) | CY915A (pt) |
DD (1) | DD102698A5 (pt) |
DE (1) | DE2300491C3 (pt) |
DK (1) | DK139359B (pt) |
FI (1) | FI54124C (pt) |
GB (1) | GB1358680A (pt) |
HK (1) | HK60077A (pt) |
HU (1) | HU164821B (pt) |
IE (1) | IE37056B1 (pt) |
IL (1) | IL41232A (pt) |
LU (1) | LU66800A1 (pt) |
NL (1) | NL7217852A (pt) |
NO (1) | NO136843C (pt) |
OA (1) | OA04285A (pt) |
SE (1) | SE398503B (pt) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2322601A1 (fr) * | 1975-09-04 | 1977-04-01 | Rhone Poulenc Ind | Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent |
AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
JPS5680585A (en) * | 1979-11-30 | 1981-07-01 | Toyoda Gosei Kk | High pressure hose |
JPS57144860A (en) * | 1981-03-04 | 1982-09-07 | Matsushita Electric Ind Co Ltd | Secondary side water pressure controller for water cooler |
US4590189A (en) * | 1982-04-02 | 1986-05-20 | Takeda Chemical Industries, Ltd. | Condensed pyrrolinone derivatives, their production and use |
JPS6169773A (ja) * | 1984-09-14 | 1986-04-10 | Takeda Chem Ind Ltd | イソインドリノン誘導体 |
JPS6297400U (pt) * | 1985-12-09 | 1987-06-20 | ||
FR2607504B1 (fr) * | 1986-12-02 | 1989-01-27 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2671800B1 (fr) * | 1991-01-17 | 1993-03-12 | Rhone Poulenc Rorer Sa | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. |
US5786357A (en) | 1991-12-02 | 1998-07-28 | Sepracor Inc. | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
AU3275993A (en) * | 1991-12-02 | 1993-06-28 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone |
AU3245593A (en) * | 1991-12-02 | 1993-06-28 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone |
AU4060599A (en) | 1998-06-09 | 1999-12-30 | Takeda Chemical Industries Ltd. | Pharmaceutical composition for treating or preventing sleep disorders |
US6339086B1 (en) | 1999-05-14 | 2002-01-15 | Swpracor, Inc. | Methods of making and using N-desmethylzopiclone |
ES2203319B1 (es) * | 2002-04-03 | 2005-03-01 | Universidad De Oviedo | Nuevos carbonatos opticamente activos como intermedios en la sintesis de (+)-zopiclona. |
AU2004305563C1 (en) | 2003-12-11 | 2011-07-07 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
MX2008000249A (es) * | 2005-07-06 | 2008-03-18 | Sepracor Inc | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. |
JP2009500425A (ja) | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US7476737B2 (en) * | 2005-09-05 | 2009-01-13 | Dr. Reddy's Laboratories Limited | Eszopiclone process |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
WO2007088073A1 (en) * | 2006-02-03 | 2007-08-09 | Synthon B.V. | Zopiclone resolution using l-tartaric acid |
WO2007104035A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007109799A2 (en) * | 2006-03-23 | 2007-09-27 | Teva Pharmaceutical Industries Ltd. | Polymorphs of eszopiclone malate |
EP2007768A2 (en) * | 2006-04-20 | 2008-12-31 | Teva Pharmaceutical Industries Ltd | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
CN101058581B (zh) * | 2006-04-21 | 2011-06-08 | 天津天士力集团有限公司 | 右佐匹克隆中间体6-(5-氯-2-吡啶基)-5,7-二氧代-6,7-二氢-5H-吡咯并[3,4-b]吡嗪的制备方法 |
MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP1904499A1 (en) * | 2006-06-26 | 2008-04-02 | Teva Pharmaceutical Industries Ltd | Process for the preparation of zopiclone |
MX2009002496A (es) * | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
EP2066355A2 (en) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
US7786304B2 (en) * | 2006-11-06 | 2010-08-31 | Centaur Pharmaceutical Pvt. Ltd. | Process for the preparation of eszopiclone |
WO2008094690A2 (en) * | 2007-01-31 | 2008-08-07 | Teva Pharmaceutical Industries Ltd. | Methods for preparing eszopiclone |
US20080305171A1 (en) * | 2007-06-07 | 2008-12-11 | Kristin Anne Arnold | Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
WO2009002552A1 (en) * | 2007-06-25 | 2008-12-31 | Teva Pharmaceutical Industries Ltd. | Racemization process of r-zopiclone |
EP2020403A1 (en) | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
WO2009063486A2 (en) * | 2007-08-06 | 2009-05-22 | Usv Limited | Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone) |
CA2692955A1 (en) * | 2007-12-11 | 2009-07-16 | Cipla Ltd | A new method for preparation of zopiclone and its polymorphs |
US8268832B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198278B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US20110053945A1 (en) * | 2007-12-19 | 2011-03-03 | Sepracor Inc. | Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine |
US8269005B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
CA2812705C (en) * | 2007-12-19 | 2015-08-18 | Sunovion Pharmaceuticals Inc. | Maleate, besylate and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
CN100467471C (zh) * | 2007-12-19 | 2009-03-11 | 齐鲁天和惠世制药有限公司 | 佐匹克隆的制备方法 |
US8198277B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8212036B2 (en) * | 2007-12-19 | 2012-07-03 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US20100221338A1 (en) | 2009-01-30 | 2010-09-02 | Sepracor Inc. | Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN105399745A (zh) * | 2015-12-17 | 2016-03-16 | 天津华津制药有限公司 | 一种吡嗪并羟基吡咯烷酮类化合物的制备方法 |
US11547706B2 (en) | 2016-06-08 | 2023-01-10 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and Fragile X syndrome |
CN106220630B (zh) * | 2016-07-23 | 2019-12-10 | 迪嘉药业集团有限公司 | 一种n-取代吡咯并[3,4-b]吡嗪-5,7(6h)-二酮的制备方法 |
AU2019279858A1 (en) * | 2018-05-29 | 2020-11-26 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
-
1972
- 1972-12-14 OA OA54780A patent/OA04285A/xx unknown
- 1972-12-28 DD DD167951A patent/DD102698A5/xx unknown
- 1972-12-29 NL NL7217852A patent/NL7217852A/xx unknown
- 1972-12-29 US US319876A patent/US3862149A/en not_active Expired - Lifetime
-
1973
- 1973-01-04 IE IE12/73A patent/IE37056B1/xx unknown
- 1973-01-04 AU AU50754/73A patent/AU466586B2/en not_active Expired
- 1973-01-04 IL IL41232A patent/IL41232A/xx unknown
- 1973-01-04 HU HURO691A patent/HU164821B/hu unknown
- 1973-01-05 CA CA160,620A patent/CA991183A/fr not_active Expired
- 1973-01-05 NO NO62/73A patent/NO136843C/no unknown
- 1973-01-05 GB GB79073A patent/GB1358680A/en not_active Expired
- 1973-01-05 BE BE793730D patent/BE793730A/xx active Protection Beyond IP Right Term
- 1973-01-05 DK DK6973AA patent/DK139359B/da not_active IP Right Cessation
- 1973-01-05 CY CY915A patent/CY915A/xx unknown
- 1973-01-05 FI FI27/73A patent/FI54124C/fi active
- 1973-01-05 JP JP48000069A patent/JPS523952B2/ja not_active Expired
- 1973-01-05 SE SE7300159A patent/SE398503B/xx active Protection Beyond IP Right Term
- 1973-01-05 LU LU66800A patent/LU66800A1/xx unknown
- 1973-01-05 AR AR246000A patent/AR195097A1/es active
- 1973-01-05 DE DE2300491A patent/DE2300491C3/de not_active Expired
- 1973-01-05 AT AT10073A patent/AT323181B/de active
-
1976
- 1976-09-08 JP JP51106831A patent/JPS5248687A/ja active Granted
- 1976-09-08 JP JP51106832A patent/JPS5248688A/ja active Granted
-
1977
- 1977-12-01 HK HK600/77A patent/HK60077A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE2300491C3 (de) | 1978-05-18 |
CY915A (en) | 1977-12-23 |
DE2300491B2 (de) | 1977-09-08 |
US3862149A (en) | 1975-01-21 |
NO136843B (no) | 1977-08-08 |
AU5075473A (en) | 1974-07-04 |
BE793730A (fr) | 1973-07-05 |
IL41232A (en) | 1975-12-31 |
JPS5248688A (en) | 1977-04-18 |
JPS5231358B2 (pt) | 1977-08-13 |
GB1358680A (en) | 1974-07-03 |
IE37056B1 (en) | 1977-04-27 |
DK139359C (pt) | 1979-07-09 |
IL41232A0 (en) | 1973-03-30 |
JPS5248687A (en) | 1977-04-18 |
FI54124C (fi) | 1978-10-10 |
DK139359B (da) | 1979-02-05 |
AT323181B (de) | 1975-06-25 |
HU164821B (pt) | 1974-04-11 |
JPS4876892A (pt) | 1973-10-16 |
FI54124B (fi) | 1978-06-30 |
LU66800A1 (pt) | 1973-07-18 |
CA991183A (fr) | 1976-06-15 |
JPS523952B2 (pt) | 1977-01-31 |
IE37056L (en) | 1973-07-07 |
JPS535315B2 (pt) | 1978-02-25 |
DE2300491A1 (de) | 1973-07-19 |
AR195097A1 (es) | 1973-09-10 |
DD102698A5 (pt) | 1973-12-20 |
AU466586B2 (en) | 1975-10-30 |
HK60077A (en) | 1977-12-09 |
NO136843C (no) | 1977-11-16 |
OA04285A (fr) | 1979-12-31 |
NL7217852A (pt) | 1973-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE398503B (sv) | Analogiforfarande for framstellning av derivat av 5,6-dihydro-pyrrolo(3,4-b)pyrazin | |
SE402592B (sv) | Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner | |
SE432767B (sv) | Forfarande for framstellning av oxazolo-(5,4-b)-pyridiner | |
SE408179B (sv) | Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner | |
SE398751B (sv) | Analogiforfarande for framstellning av pyrazolo/1,5-a/pyrimidiner | |
SE390819B (sv) | Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat | |
SE381047B (sv) | Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat | |
SE7608808L (sv) | Forfarande for framstellning av nya derivat av tiazolo/3,4-b/isokinolin | |
SE389499B (sv) | Analogiforfarande for framstellning av triazolo(4,3-a)(1,4)bensodiazepin-derivat | |
SE411451B (sv) | Analogiforfarande for framstellning av derivat av imidazo(4,5-b)pyridiner | |
SE402012B (sv) | Analogiforfarande for framstellning av s-triazolo(1,5-a)(1,4)diazepinderivat | |
SE410604B (sv) | Analogiforfarande for framstellning av pyrazolo(3,4-e)(1,4)diazepinforeningar | |
NO136713C (no) | Analogifremgangsm}te for fremstilling av 1-oksa-3,8-diazaspiro(4,5)dekan-derivater med neuroleptisk virkning | |
CH551431A (fr) | Preparation de derives de la pyrrolo (3,4-b) pyridine. | |
SE399895B (sv) | Forfarande for framstellning av s-triazolo(3,4-b)benstiazoler | |
CA1013747A (fr) | Procede de preparation de derives du 9h-pyrido/3,4-b/indole | |
SE395150B (sv) | Forfarande for framstellning av derivat av pyrazol(3,4-b)pyridinketoner | |
SE399894B (sv) | Forfarande for framstellning av nya derivat av imidazo(2,1-b)tiazol | |
SE397093B (sv) | Forfarande for framstellning av oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazinderivat | |
SE380804B (sv) | Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4) | |
SE398122B (sv) | Analogiforfarande for framstellning av pyrazino/1,2-a/indol-2-karboxamidiner | |
SE407685B (sv) | Analogiflrfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat | |
SE397832B (sv) | Analogiforfarande for framstellning av s-triazolo(4,3-a)(1,4)bensodiazepinderivat | |
DK139872B (da) | Analogifremgangsmåde til fremstilling af pyrimido(1,2-a)(1,4)benzodiazepin-3-on-derivater. | |
SE404367B (sv) | Forfarande for framstellning av derivat av homofolsyra |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCG | Supplementary protection certificate granted |
Free format text: 7300159, EXPIRES: 19990306 |